Compare Aurobindo Pharma with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ALEMBIC AUROBINDO PHARMA/
ALEMBIC
 
P/E (TTM) x 10.5 20.2 52.2% View Chart
P/BV x 1.4 0.8 184.3% View Chart
Dividend Yield % 0.8 0.3 259.4%  

Financials

 AUROBINDO PHARMA   ALEMBIC
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
ALEMBIC
Mar-21
AUROBINDO PHARMA/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,023123 833.5%   
Low Rs33332 1,041.7%   
Sales per share (Unadj.) Rs422.82.9 14,768.4%  
Earnings per share (Unadj.) Rs92.00.5 17,063.3%  
Cash flow per share (Unadj.) Rs110.00.7 15,883.5%  
Dividends per share (Unadj.) Rs4.000.20 2,000.0%  
Avg Dividend yield %0.60.3 228.2%  
Book value per share (Unadj.) Rs374.389.5 418.4%  
Shares outstanding (eoy) m585.94256.78 228.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.627.0 5.9%   
Avg P/E ratio x7.4143.5 5.1%  
P/CF ratio (eoy) x6.2111.7 5.5%  
Price / Book Value ratio x1.80.9 209.5%  
Dividend payout %4.337.1 11.7%   
Avg Mkt Cap Rs m397,39819,868 2,000.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35,350226 15,644.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m247,746735 33,699.6%  
Other income Rs m3,809109 3,488.9%   
Total revenues Rs m251,555844 29,793.4%   
Gross profit Rs m81,480104 78,143.1%  
Depreciation Rs m10,55439 26,786.5%   
Interest Rs m7454 20,577.3%   
Profit before tax Rs m73,990170 43,418.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,09832 62,805.3%   
Profit after tax Rs m53,892138 38,936.3%  
Gross profit margin %32.914.2 231.9%  
Effective tax rate %27.218.8 144.7%   
Net profit margin %21.818.8 115.5%  
BALANCE SHEET DATA
Current assets Rs m198,2351,021 19,416.9%   
Current liabilities Rs m106,652594 17,950.3%   
Net working cap to sales %37.058.1 63.7%  
Current ratio x1.91.7 108.2%  
Inventory Days Days1910,191 0.2%  
Debtors Days Days52686 7.5%  
Net fixed assets Rs m135,77823,069 588.6%   
Share capital Rs m586514 114.1%   
"Free" reserves Rs m218,71322,457 973.9%   
Net worth Rs m219,29922,970 954.7%   
Long term debt Rs m1,6840-   
Total assets Rs m334,01324,090 1,386.5%  
Interest coverage x100.348.1 208.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70 2,430.5%   
Return on assets %16.40.6 2,774.4%  
Return on equity %24.60.6 4,078.3%  
Return on capital %33.80.8 4,463.7%  
Exports to sales %53.81.5 3,647.6%   
Imports to sales %16.46.1 270.4%   
Exports (fob) Rs m133,24811 1,229,223.2%   
Imports (cif) Rs m40,61545 91,125.9%   
Fx inflow Rs m133,24811 1,229,223.2%   
Fx outflow Rs m44,94645 100,842.7%   
Net fx Rs m88,302-34 -261,791.3%   
CASH FLOW
From Operations Rs m33,289-22 -152,562.8%  
From Investments Rs m5,987-347 -1,723.4%  
From Financial Activity Rs m-13,648-154 8,884.3%  
Net Cashflow Rs m25,831-523 -4,940.8%  

Share Holding

Indian Promoters % 48.8 70.9 68.8%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.3 5.8 659.2%  
FIIs % 20.8 1.1 1,859.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 29.1 165.4%  
Shareholders   338,639 80,135 422.6%  
Pledged promoter(s) holding % 14.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Lower as Realty & IT Stocks Witness Selling; Asian Paints, Berger Paints Slump 8%(Closing)

After opening on a positive note, Indian share markets failed to hold early gains and ended the day lower.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


May 25, 2022 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS